Recent Publications

Phillips, SL, Williams, CB, Zambrano, JN, Williams, CJ, and Yeh, ES (2017) Connexin 43 in the development and progression of breast cancer: What’s the connection?. International Journal of Oncology51(4): 1005-1013.

Zambrano, JN, Neely, BA, and Yeh, ES (2017) Hormonally Up-regulated Neu-associated Kinase: A novel target for breast cancer progression. Pharmacol Res. 119: 188-197.

Grek, CL, Rhett, JM, Bruce, JS, Ghatnekar, GS, and Yeh, ES (2016) Connexin 43, Tumor Suppressor: Missed Connections? Cancer Letters 374: 117–126.

Phelps-Polirer, K, Abt, MA, Smith, D, and Yeh, ES (2016) Co-targeting of JNK and HUNK in HER2-positive Breast Cancers Resistant to Trastuzumab and Lapatinib. PlosOne 11 (4): e0153025.

Zambrano, J and ES Yeh (2016) Autophagy and Apoptotic Crosstalk: Mechanism of Therapeutic Resistance in HER2-positive Breast Cancer. Breast Cancer Basic and Clinical Research. 10: 13-23

Abt, M.A., Grek, C.L., Ghatnekar, G.S., Yeh, E.S. (2016) Evaluation of Lung Metastasis in Mouse Mammary Tumor Models by Quantitative Realtime PCR. J. Vis. Exp. (107), e53329.

Williams, CB, Yeh, ES, and Soloff, AC (2016) Tumor-associated Macrophages: Unwitting Accomplices in Breast Cancer Malignancy. npj Breast Cancer. 2, 15025.

Williams, CB, Soloff, AC, Either, SP, and Yeh, ES (2015) Perspectives on Epidermal Growth Factor Receptor Regulation in Triple-negative Breast Cancer. Advances in Cancer Research. 127:253-281.

Grek, CL, Rhett, JM, Bruce, JS, Abt, MA, Ghatnekar, GS, and Yeh, ES (2015) Targeting connexin 43 with α–connexin carboxyl-terminal (ACT1) peptide enhances the activity of targeted inhibitors in breast cancer. BMC Cancer, 15: 296.

Yeh, ES, Abt, MA, and Hill, EG. (2015) Regulation of Cell Survival by HUNK Mediates Breast Cancer Resistance to HER2 Inhibitors. Breast Cancer Research and Treatment. 149 (1), 91-8.

 

Advertisements